A CT-guided core needle biopsy targeting the central region of the pleura mass (Figure 1C, puncture site) yielded necrotic debris without viable tumor cells, consistent with the high central necrosis rate (30–45%) in SMARCA4-deficient sarcomas. This evidence concerns the gene SMARCA4 and neoplasm.